Beam Therapeutics Inc. (BEAM)
NASDAQ·Healthcare·Biotechnology
$30.69
+5.23%
Mkt Cap $3.13B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (17 analysts)
$40.86
Range $26.00 – $74.00
Implied Upside
+33.1%
Consensus $40.86 vs current $30.69
NASDAQ·Healthcare·Biotechnology
$30.69
+5.23%
Mkt Cap $3.13B
Buy
3
Hold
0
Sell
0
Price Target (17 analysts)
$40.86
Range $26.00 – $74.00
+33.1%
Consensus $40.86 vs current $30.69